Skip to main content

Study M618

Study name

Jaddoa E 2020

Title

Effect of antidepressant drugs on the brain sphingolipid system

Overall design

The aim of this study was to investigate the action of antidepressant drugs on sphingolipid levels in rat brain regions, plasma and in cultured mouse macrophages. Sprague-Dawley rats were divided into the following 8 groups (n = 12 in each group): (1) acute paroxetine control group (single injection of vehicle, i.p.), (2) acute paroxetine group (single injection of paroxetine at the dose of 5 mg/kg, i.p.), (3) chronic paroxetine control group (chronic injection of vehicle for 15 days, i.p.), (4) chronic paroxetine group (chronic injection of paroxetine for 15 days, at the dose of 5 mg/kg, i.p.), (5) acute desipramine control group (single injection of vehicle, i.p.), (6) acute desipramine group (single injection of desipramine at the dose of 10 mg/kg, i.p.), (7) chronic desipramine control group (chronic injection of vehicle for 15 days, i.p.), and (8) chronic desipramine group (chronic injection of desipramine for 15 days, at the dose of 10 mg/kg, i.p.). Hippocampus, prefrontal cortex, striatum, and plasma levels of sphingosine were analysed using LC-MS.

Study Type

Type3;

Data available

Unavailable

Organism

Rat; Sprague-Dawley rat;

Categories of depression

Healthy individuals; Healthy individuals; Healthy individuals;

Criteria for depression

Not reported

Sample size

96

Tissue

Central; Brain; Hippocampus;

Central; Brain; Prefrontal cortex;

Peripheral; Blood; Plasma;

Central; Brain; Striatum;

Platform

MS-based; LC-MS: Agilent 1260 Infinity LC-system (Agilent Technologies) with on-line LC-MS detector;

PMID

32403969

DOI

10.1177/0269881120915412

Citation

Jaddoa E, Masania J, Masiero E, et al. Effect of antidepressant drugs on the brain sphingolipid system. J Psychopharmacol. 2020;34(7):716-725.

Metabolite

Sphingosine;